Breaking News

Cognate Compliant with EU GMPs

For the manufacture of advanced therapeutic medicinal products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cognate BioServices, a contract development and manufacturing organization (CDMO) in the global cellular therapies industry, has received a statement of compliance for the manufacture and development of advanced therapy medicinal products (ATMPs) for EU/UK.   “We’re very proud to announce that we are now in a position to serve patients in the EU and the UK with our Memphis-based commercial manufacturing team and state of the art GMP manufacturing facility,” said J. Kelly Ganjei, chie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters